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Abstract
Background: Knee osteoarthritis (OA) has been linked to maladaptive plasticity in the brain, which may contribute
to chronic pain. Neuromodulatory approaches, such as Transcranial Direct Current Stimulation (tDCS) and Peripheral
Electrical Stimulation (PES), have been used therapeutically to counteract brain maladaptive plasticity. However, it is
currently unclear whether these neuromodulatory techniques enhance the benefits of exercise when administered
together. Therefore, this protocol aims to investigate whether the addition of tDCS combined or not with PES
enhances the effects of a land-based strengthening exercise program in patients with knee OA.
Methods: Patients with knee OA (n = 80) will undertake a structured exercise program for five consecutive days.
In addition, they will be randomized into four subgroups receiving either active anodal tDCS and sham PES (group
1; n = 20), sham tDCS and active PES (group 2, n = 20), sham tDCS and PES (group 3, n = 20), or active tDCS and
PES (group 4, n = 20) for 20 min/day for five consecutive days just prior to commencement of the exercise program.
The primary outcomes will be subjective pain intensity (VAS) and related function (WOMAC). Secondary outcomes will
include quality of life (SF-36), anxiety and depression symptoms (HAD), self-perception of improvement, pressure pain
thresholds over the knee, quadriceps strength, and quadriceps electromyographic activity during maximum knee
extension voluntary contraction. We will also investigate cortical excitability using transcranial magnetic stimulation.
Outcome measures will be assessed at baseline, 1 month after, before any intervention, after 5 days of intervention,
and at 1 month post exercise intervention.
Discussion: The motor cortex becomes less responsive in knee OA because of poorly adapted plastic changes, which
can impede exercise therapy benefits. Adding tDCS and/or PES may help to counteract those maladaptive plastic
changes and improve the benefits of exercises, and the combination of both neuromodulatory techniques must have
a higher magnitude of effect. Trial registration: Brazilian Registry on Clinical Trials (ReBEC) – Effects of electrical
stimulation over the skull and tight together with exercises for knee OA; protocol number RBR-9D7C7B.
Trial registration: ID: RBR-9D7C7B. Registered on 29 February 2016.
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Background
Osteoarthritis (OA) is a chronic degenerative disease, pri-
marily affecting the articular cartilage and subchondral
bone of a synovial joint [1]. Radiographic features of OA
include degradation of the articular cartilage, subchondral
sclerosis and osteophyte formation [2, 3]. OA primarily af-
fects the large, weight-bearing joints such as the knee and
hip [4, 5]. The hallmark symptom of OA is chronic joint
pain, which contributes to functional limitation and is a
major cause of reduced quality of life. OA is the leading
cause of disability affecting up to 15% of the global popu-
lation, that equates to approximately 630 million people
worldwide [6]. In South America, the prevalence of arth-
ritis and rheumatism has been reported to range between
23.8 and 56.0% [7]. In Brazil, direct OA data is not avail-
able but chronic knee pain affects approximately 11.2% of
the population [8].
Knee OA affects around 10% of people over 55 years
old, a quarter of whom are severely disabled [2]. Thus,
knee OA poses a considerable economic burden to the
community [9] due to indirect expenses incurred by pa-
tients, such as home adaptations, medications [10, 11],
costs incurred for loss of employment and productivity
[12]. A recent study in the United States revealed that
lifetime direct medical costs of people with knee OA
totaled US$129,600 [13]. Therefore, knee OA is consid-
ered a significant global public health problem, especially
with an ageing population.
The development of OA is multifactorial (Fig. 1) but
some main risk factors have been identified, and these in-
clude obesity, female gender, and previous knee injury
[14]. However, previous research also noted the influence
of age, genetic susceptibility, trauma (acute or repetitive),
muscle weakness, joint laxity, and abnormal mechanical
forces, such as repetitive kneeling and squatting, as im-
portant risk factors [15].
Abnormal mechanical stresses can impede natural re-
pair and remodeling processes of the articular cartilage
[16, 17]. The source of abnormal mechanical stress is
diverse but has been associated with decreased postural
control [18], muscle weakness and increased co-activation
[19, 20], abnormal cumulative load [21, 22], joint instabil-
ity [23], and the presence of abnormal tissue inside the
joint (e.g., polymers of homogentisic acid oxidase in osteo-
necrosis) [16].
Conservative management, such as exercise therapy, de-
signed to address issues like postural control and muscle
dysfunction have limited success [24, 25]. Although the in-
fluence of OA on muscle strength is controversial,
strengthening, stretching, and aerobic exercise are gener-
ally recommended [26]. A recent systematic review that
pooled data from 44 trials concluded that land-based
therapeutic exercises provide short-term pain relief (12
points/100) and improved physical function (10 points/
100) for people with knee OA [27, 28]. After around 6
months, the benefits of exercise generally plateau, and
pain often persist [27, 29]. The refractoriness to exercises
needs to be addressed, and many factors may contribute.
An alternative explanation for the presence of persist-
ent pain in OA patients is maladaptive neuroplastic
changes in the spinal cord and brain [30, 31]. For ex-
ample, a recent magnetic resonance imaging (MRI)
study has demonstrated that patients with knee OA
showed decreased volume in the somatosensory, insu-
lar, and motor cortices bilaterally. Two other clinical
pain conditions were assessed including chronic back
pain and complex regional pain syndrome. These
changes are more pronounced in patients with a long
duration of chronic pain, suggesting a positive correl-
ation between chronicity of pain and decreased gray
matter density. Similar reduction in volume has also
been demonstrated in subcortical areas including the
caudate nucleus and hippocampus in patients with knee
OA and reduced volumes in those regions compromise
motor control and learning [32].
The results from these imaging studies suggest that
chronic pain is associated with functional changes in the
brain. Studies using transcranial magnetic stimulation
Fig. 1 Multifactorial features of knee osteoarthritis composed of intrinsic and extrinsic factors
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(TMS) have also provided useful information regarding
the nature of corticomotor plasticity in chronic pain
[33]. For example, several previous studies have demon-
strated that various pain conditions, such as low back
pain and fibromyalgia, are associated with decreased
amplitude of motor evoked potentials (MEPs) and
intracortical inhibition (ICI). Similar changes were also
reported in studies utilizing experimental muscle pain
[34–36]. To date, only few studies have examined cor-
tical plasticity in patients with knee OA. Hunt et al.
(2011) [37] in a single case study demonstrated that
MEPs of the rectus femoris were decreased in unilateral
knee OA, but this change could be reversed after 8
weeks of muscle strengthening, and corresponded to
pain decrease. Kittelson et al. (2014) [38] found a sig-
nificant negative association between the resting motor
threshold (RMT) and pain, but no differences in cor-
tical excitability measures between controls and OA
subjects. Tarragó et al. (2016) demonstrated in patients
with knee OA an association between chronicity of pain
and reduction in intracortical inhibition [39]. Taken to-
gether, these findings suggest a central component re-
lated to chronic pain secondary to knee OA mostly
indicating changes in M1 excitability, either decreased
MEPs or motor thresholds, and decreased intracortical
inhibition mechanisms and suggesting dysfunction in
the interneurons which contribute to intracortical in-
hibitory circuits. Given the high functional connectivity
of the motor cortex to other brain areas known to be
involved in the pain matrix [40], such as the prefrontal
cortex and thalamus [41], it might reflect not only
impaired motor cortical function but also suggest a dys-
function in network connectivity as a potential mecha-
nisms mediating the development of chronic pain [42].
As eluded to earlier, there is a growing body of evi-
dence that many chronic pain disorders, including OA
are associated with changes in motor cortical function
[42–44]. Therefore, it is reasonable to suggest that treat-
ment modalities that specifically target motor cortical
function might have therapeutic value. It is well known
that both exercises and electrical stimulation can induce
cortical plasticity [45, 46]. It is possible that treatment
effect maybe enhanced if exercise is combined with elec-
trical stimulation. This seems as a relevant option to re-
verse these changes, but they may be not sufficient to
accomplish a long-term effect and interfere with mal-
adaptive changes in the brain [47]. Associating exercises
with electrical stimulation may be an option to enhance
therapy efficacy. It has been shown previously that cor-
tical excitability could be modulated both centrally using
TMS and TES [48, 49] or peripherally using electrical
stimulation [50, 51], or the combination of both [52]. A
novel therapeutic technique that has the potential to
ameliorate maladaptive neuroplasticity in knee OA is
Transcranial Direct Current Stimulation (tDCS). tDCS is
a simple, safe, and non-invasive technique, which involves
the application of low-intensity direct electric current to
the scalp [53]. tDCS is known to acutely alter excitability
of the motor cortex [54–56]. Anodal stimulation of the
primary motor cortex can enhance excitability by increas-
ing the neuronal resting membrane potential, while cath-
odal stimulation decreases it [57]. Anodal stimulation can
induce analgesic effects [58, 59], probably through the
modulation of neuronal membrane channels resulting in
local and distant plastic changes [60]. To date, tDCS has
been tested in a number of pain states with low-to-
moderate effect size with an averaged reduction in a Visual
Analogue Score (VAS) pain score ranging between 0.18
and 0.35 [59, 61–64].
However, studies using computational modeling with
a Finite Elements Model (FEM) have demonstrated low
focality and dispersion of current density through the
scalp during tDCS [65, 66] which may contribute at
least in part to its reported low effect size on clinical
outcomes. Using tDCS alone, without any other active
intervention, may be another explanation for its low ef-
ficacy reported by previous studies [61]. One way to
test the above hypotheses is to investigate to effects of
combining tDCS with Peripheral Electrical Stimulation
(PES). PES, similar to tDCS, PES can also transiently
modulate motor cortical excitability in a bidirectional
way. Sensory and nociceptive PES decrease M1 excit-
ability, while motor PES increases M1 excitability [50].
Previous studies have investigated the effect of combin-
ing these two neuromodulatory techniques – Schabrun
et al. (2013) [52] have demonstrated that when anodal
tDCS is combined with motor PES (both excitatory
techniques), it neutralizes the excitatory effect of each
other, leading to no significant changes in M1 excitabil-
ity. This phenomenon can be explained by metaplastic
mechanisms (homeostatic plasticity), a phenomenon
necessary to maintain physiological integrity of a bio-
logical system through the limitation extreme changes
in functioning [50, 67]. However, the combination of an
excitatory brain stimulation technique (anodal tDCS)
with an inhibitory peripheral stimulation (sensory
PES) produced a more focal modulation, as seen in
Paired Associative Stimulation. In this technique, a
TMS single pulse is associated with an electric pulse
in the median nerve [68] to increase or decrease excit-
ability depending on the intensity or interstimulus
intervals [69, 70]. Anodal tDCS has been combined
with sensory PES in chronic low back pain individuals,
resulting in a more pronounced pain reduction, and
M1 reorganization [71]. Taken these results together,
we hypothesized that the combination of anodal tDCS
with sensory PES may have additive effects to exer-
cises in people with knee OA.
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There is encouraging evidence to suggest that the com-
bination of tDCS and sensory PES may have the potential
to reduce pain. However, it is currently unknown whether
this combined approach is effective in patients with knee
OA. Furthermore, it is unclear whether neuromodulation
can augment the beneficial effects of exercise in patients
with knee OA. Therefore, the double-blind, randomized,
parallel study model was selected for this hypothesis.
Hypothesis
The addition of anodal tDCS and sensory PES to an ex-
ercise program will have a more pronounced effect on
decreasing pain and improving function in people with
knee OA compare to exercise alone. Specifically, our
hypothesis is that this combination will promote a more
robust decrease of pain magnitude and improvement in
function and quality of life. We further hypothesize that
these changes will be correlated with increased excitability
of corticomotor and cortico-cortical connections in M1,
and quadriceps strength, independent of the presence of
anxiety and depression. We also hypothesize that par-
ticipants submitted to this regimen will maintain the
benefits of stimulation 1 month after the end of the




The primary aim is to determine if the addition of tDCS
and PES to an exercise program is more effective in
reducing pain, improving function and quality of life in
patients with chronic knee OA compared to exercise
alone.
Secondary
To assess the effect of combining tDCS, PES and exercise,
on motor threshold, cortical excitability, and cortical silent
period of the rectus femoris, vastus medialis, and vastus
lateralis muscles to exercise alone.
To correlate the neurophysiological findings with pa-
rameters of pain, muscle strength, global function related
to OA, anxiety and depression symptoms, quality of life,
and treatment perception from subjects.
Methods
Target population and sample
Participants will be recruited from public announcements
and interviewed at the Laboratory of Functional Electrical
Stimulation, Federal University of Bahia, Salvador, Bahia,
Brazil. Sample size was estimated based on an effect size
of 0.50 on pain relief measured by VAS score, study power
of 80%, and four groups, with a total of 15 subjects per
group. Total sample size was increased to 20 to account
for loss to follow-up.
Inclusion criteria
Participants will be included in this study if they have
OA of the knee based on the clinical and radiological
criteria defined by the American College of Rheumatol-
ogy Society. These criteria include:
1. Age older than 50 years, knee pain on most days of the
past month, osteophytes on plain X-ray and pain or
difficulty in rising from sitting or climbing stairs [72]
2. Have a Chronic Pain Grade (CPG) score equal to or
greater than II [73, 74]
Exclusion criteria
Participants will be excluded if they:
1. Have a contraindication for TMS use such as:
existence of metal in the skull or implanted devices,
epilepsy history, pregnancy, use of drugs that might
affect cortical electrical activity (anticonvulsants,
antidepressants or antipsychotics), and complications
with exposure to magnetic fields (TMS or MRI)
2. Have a disease history that might interfere with the
knee OA, becoming a confounding bias –
fibromyalgia, systemic lupus erythematosus,
fractures of the knee region, knee prosthesis, low
back impairment – that cause symptoms in the knee
and peripheral nerves
3. Are incapable of comprehend the content from the
assessments tools
Discontinuity criteria
Procedures will be discontinued if:
 Moderate-to-severe adverse events are present, even
related to electrical stimulation, exercises, or
electrophysiological assessment
 Participants who initiate any other medical
intervention to treat knee OA or other that may
interfere with the results of this study
Subjects who initiate any of the treatments described
below will be discontinued from the study:
 Physiotherapeutic treatment (conventional
physiotherapy, postural re-education, pilates)
 Psychiatric treatment (associated anxiety and
depression)
 Inclusion of new drug treatment for pain due to
knee OA
 Treatment for weight reduction for obese
individuals (aerobic exercise program)
 Fitness muscle training
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Study design
Study participants will be assessed on four different oc-
casions: (1) baseline assessment (day 1) 1 month before
the commencement of intervention; (2) reassessment a
month later (day 30), (3) participants will be submitted
to an intervention consisting of electrical stimulation ap-
plied before the structured exercise program for five
consecutive days, (d) reassessment at the completion of
the exercise program (day 36) and 1 month after the last
day of intervention (day 66) (Fig. 2).
An experienced physiotherapist blinded to the study will
perform initial neurophysiological assessment. The sub-
jects will be randomly allocated by the research manager,
which will only be involved in this study phase, at one of
the four groups through a lottery system generated from a
random-number table (www.randomization.com). Alloca-
tion sequence implementation mechanism will be by
opaque and sealed envelopes. Access to this envelope will
be exclusive to the physiotherapist who will apply the
intervention techniques. The absence of blinding will not
be allowed in this study. In the event of a breach of the
blinding, the participant will be removed from the re-
search protocol. The SPIRIT checklist with the registration
events, interventions, evaluations and visits for partici-
pants can be verified in Fig. 3.
The same physiotherapist that performed the baseline
assessment will teach and supervise the exercise pro-
gram, common to all groups. Another researcher will be
responsible for administering electrical stimulation inter-
ventions (tDCS, PES, and their combinations) and will
not be involved in any other component of the study.
The allocation concealment will be evaluated at the end
of the intervention by custom questionnaire. The study
participants will complete an adverse effect question-
naire at the end of the trial.
Research groups
All groups will receive a supervised exercise program:
1. Active anodal tDCS associated with sham PES (n = 20)
2. Sham tDCS associated with active PES (n = 20)
3. Sham tDCS associated with sham PES (n = 20)
4. Active anodal tDCS associated with active PES (n = 20)
Strategies to improve adhesion to the intervention
All the participants will receive compensations for trans-
portation to and from the testing laboratory as well as a
meal allowance. At the end of the study the intervention
that promoted greater reduction in pain will be offered to
those who did not receive it. To minimize withdrawal of
participants during the study, a collaborating researcher
will make telephone contact to confirm the appointment.
Despite this, if the participant is absent, they may attend




For the electrical stimulation protocol, participants will be
comfortably seated on a chair at the Functional Electrical
Stimulation Laboratory in the Health Science Institute of
Federal University of Bahia. The procedures will be clearly
explained and subjects will be encouraged to ask questions
regarding the experimental procedures. The tDCS proto-
col will consist of a direct current stimulation lasting 20
min, of 2-mA amplitude, for five consecutive days before
the exercise protocol, through a proper stimulator device
(Soterix, New York, NY, USA). The anode will be placed
on the primary motor cortex (M1 – C3 or C4, per the 10/
20 international electroencephalogram (EEG) system)
contralateral to the painful knee or the most symptomatic
one in case of bilateral pain. The cathode will be placed
on the opposite supraorbital region (Fp1 or Fp2, per 10/20
international EEG system). For the sham tDCS group the
electrodes will be placed and the electric current con-
nected for 30 s, then turned off and removed at the end of
the 20-min period.
Fig. 2 Participants’ assessment occurs in sequential moments: a Baseline assessment (day 1) – 1 month before the beginning of the intervention.
b Revaluation 1 month later (day 30). c intervention for five consecutive days. d Reassessment at the conclusion of the exercise program (day 36)
and 1 month after the last intervention day (day 66)
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PES of the knee joint will be performed on its lateral
and medial portions with a clinical pulse generator
(Endophasys, KLD Medical Products, Brazil). Only the
symptomatic side will be stimulated or the more symp-
tomatic (in case of bilateral symptoms). A biphasic, sym-
metric current will be used for stimulation with a 0.25-
ms pulse width, frequency of 10 Hz, with an amplitude
at the sensory threshold, lasting 20 min, with the subject
sitting comfortably at rest. Two surface electrodes of
silicon-carbon bond, 5 × 5 cm, fixed on skin by Velcro
will be used at each side of the joint. For sham stimula-
tion the same electrode montage will be used with active
stimulation on a sensory threshold for 30 s and then
returned to zero. Electrodes will be removed after 20
min. tDCS and PES will start and stop at the same time
during each session.
Exercise
The exercises will be based on a previously described
protocol (Bennel and Dobson (2014) [75]), and will be
taught by a trained physiotherapist at the first day of
intervention. Assistance to proper performance and pro-
gression will happen during the next 4 days’ interven-
tion. In summary, the protocol consists on strengthening
exercises for muscles of the knees and hips. The inter-
vention will be carried out with three series of 8 to 12




The intensity of the symptomatic knee (or the knee with
greatest symptoms if both knees are affected) will be
assessed before and after each intervention session. In case
of equal magnitude of pain on both knees, the dominant
side will be evaluated. Pain magnitude will be assessed at
all meetings with the participants, through a 0–10 VAS.
When this meeting includes the intervention, pain will be
assessed before and after the procedures. In general evalu-
ations, the pressure pain threshold on the medial and
lateral sides of both knees will be assessed using a digital
pressure pain threshold (EMG System, São José dos
Campos, Brazil). Pressure pain threshold at the medial
and lateral sides of both knees will be assessed using a
digital pressure pain threshold meter (EMG System, São
José dos Campos, Brazil) on days 1, 30, 36, and 66. The
mean of three measures at each point will be used for
analysis. Together, pain, stiffness and physical function
will be assessed through the Brazilian version of the
Western Ontario and McMaster Universities Osteoarth-
ritis Index (WOMAC) [76].
Secondary outcomes
The secondary outcomes will be assessed at each of the
four general assessment sessions (days 1, 30, 36, and 66).
Quality of life will be assessed through the 36-item Short
Fig. 3 Schematic diagram of enrollment, interventions, assessments, and visits for participants
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Form (SF-36) questionnaire [77] and symptoms of de-
pression and anxiety through the Hospital Anxiety and
Depression Scale (HADS) [78].
Quadriceps muscle strength will be assessed through a
digital dynamometer (EMG System, Brazil) positioned at
a right angle to the ankle. The subject will be seated with
hip and knees at 90°. The make test paradigm will be
used. Three maximal isometric contractions of both
knees will be recorded, each lasting 6 s, with 1 min rest
between them. Standard verbal encouragement will be
provided to all participants to generate maximal force.
The average of the three recordings will be used for sub-
sequent analysis.
Cortical excitability will be assessed using a Magstim
BiStim stimulator (Magstim Co. Ltd, Dyfed, UK). The
quadriceps area corresponding to the painful knee and the
anterior superior iliac spine (ASIS) will be cleaned with al-
cohol. Self-adhesive electromyography (EMG) electrodes
Ag/AgCl (Noraxon, Scottsdale, AZ, USA) will be posi-
tioned on the muscle belly of the rectus femoris, vastus
lateralis and vastus medialis muscles. The RMS EMG ac-
tivity will be pre-amplified x3000, filtered at 1–2000 Hz,
and sampled at 4000 Hz using a 1401 acquisition system
and Signal v.06 software (Cambridge Electronic Design,
Cambridge, UK). During the testing procedure the subject
should extend the knee until an EMG activity of 100 μV is
reached. The participant will be asked to maintain this
level of contraction during the entire evaluation period.
The vertex will be marked at the intersection of the
interaural and nasion to inion lines according to the 10/
20 EEG system. The subject will be comfortably seated on
a proper chair and kept awake during the entire evaluation
protocol. A polyester cap previously marked with a 1 × 1-
cm grid will be positioned on the subject’s head and will
serve as reference for the TMS. The TMS will be applied
by the examiner using a figure-of-eight coil to deliver sin-
gle and paired pulsed TMS to the motor cortex, while
RMS EMG activity will be monitored in real time through
Signal v.06 software (Cambridge Electronic Design,
Cambridge, UK). The spot where a balanced EMG activity
is found for the rectus femoris, vastus lateralis, and vastus
medialis activation will be considered as the “hot spot.”
Active motor threshold (AMT) will be estimated as the
minimum stimulator intensity that evokes responses in
the target muscle of at least 200 μV of peak-to-peak
amplitude. AMT will be estimated through computer soft-
ware (Motor Threshold Assessment Tool, www.clinicalre
searcher.org). MEP amplitude will be estimated by the
mean of 10 pulses at 120% of AMT. For short-interval
intracortical inhibition (SICI) and intracortical facilitation
(ICF), a subthreshold conditioning pulse (80% AMT) will
be delivered followed by a suprathreshold test stimulus
(120% AMT) separated by pre-defined intervals of 2 ms
for SICI and 15 ms for ICF.
Potential TMS risks
Potential risks were described by Rossi et al. (2009) and
Lefaucheur et al. (2011) [79, 80]. All potential risks are
listed and summarized on the subject’s Informed Consent
Form. Subjects will complete an adverse effects question-
naire for TMS and tDCS just after each intervention.
Ethical aspects
The protocol meets the legal requirements involving
research in humans, according to the Declaration of
Helsinki. All participants will be briefed on the objectives
and will sign the Consent Form. This protocol was ap-
proved by the Ethics Committee of the Health Sciences
Institute of the Federal University of Bahia under number
1,378,100, and in the Brazilian System of Clinical Trials
Registration (REBEC) under number RBR-9D7C7B. Pos-
sible changes to the protocol will be communicated to the
Ethics Committee, REBEC, and participants. The findings
will be forwarded to the participants and collaborators
through a simplified report in an accessible language.
Documents will not be made public without the permis-
sion of the participant and the resulting publications will
have no identification of the subjects. The data will be
archived with the principal investigator for 5 years and
then destroyed. Researchers are physiotherapists who are
able to help in cases of research-related harms.
The authors of the publications will be considered the
researchers who meet the following criteria:
1. Substantially contributing to the design and
planning, or acquisition of data, or analysis and
interpretation of data
2. Participate in article writing or critical intellectual
review
3. Review and approve the final version to be published
The researchers declare no conflicts of interest with fi-
nancial agents and access to data will be restricted to
key researchers.
Consent to publish
Written consent will be obtained from the participants
for the publication of their individual data and accom-
panying images in this manuscript. The Consent Form
will be archived by the researcher in charge and will be
available for review by Editor-in-Chief. The images pro-
vided to illustrate the exercise program were granted by
one of the collaborators through the term of assignment
of the image use.
Data analysis
All statistical procedures will be performed according to
the principles of intention-to-treat. A linear mixed model
will be used to identify the differences in pain intensity
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(VAS), PPT, and WOMAC scores between the groups with
real stimulation (tDCS, PES and tDCS + PES) and sham
interventions across the periods of assessment (factors
intervention and time). Anxiety and depression will be
analyzed as covariables. When necessary, post hoc compari-
sons will be performed using the Bonferroni correction for
multiple comparisons. Analysis of the cumulative propor-
tion of respondents with different cutoff points will be
employed to analyze clinical analgesic response between
groups according to Farrar et al. (2006) [81]. Correlation
measurements will be performed between the clinical
variables (VAS, PPT, and WOMAC scores and secondary
variables (quality of life and TMS variables PEM, IIC and
FIC). All data will be analyzed using software SPSS v.23.0.
Statistical significance will be set as p < 0.05.
Discussion
We adhere to the recommendations of SPIRIT (Standard
Protocol: Recommendations for Interventional Testing)
in the development and reporting of our protocol (Add-
itional file 2). The exercises have demonstrated positive
effects on pain and function in various chronic pain con-
ditions [82]. The results obtained can be optimized when
associated with non-invasive neuromodulatory tech-
niques. The procedures with the most evidence are from
tDCS [83–85] and PES [86, 87]. The combination with
the largest effect size is not sufficiently elucidated in the
scientific literature and ideal estimation parameters of
the modalities are controversial. The present study used
the parameters with the highest scientific evidence for
the proposed clinical outcomes.
Exercise combined with neuromodulatory techniques
may reverberate in the motor cortex [46, 70]. This fact
suggests that clinical and electrophysiological variables
are positively correlate. Reorganization of the quadri-
ceps motor cortex after an exercise program supports
this correlation [70].
Clinical impacts may represent significant changes in
the cortical activity of the subject with knee OA. The
understanding of the relationship between brain and
muscle may lead the physician to propose interventions
that amplify this connection and significantly improve
function.
Benefits
All individuals will receive specific follow-up from phys-
iotherapists, who will guide the implementation and
evolution of therapeutic exercises with a good level of
evidence for the treatment of OA of the knee. Addition-
ally we believe that the electrical resources tested can in-
crease the effects of the exercises. If these resources
prove to be effective, the best therapy will be offered to
those who did not receive it.
Trials status
Estimated enrollment is 15 participants. The study start
date was June 2016, and the estimated study completion
date is June 2018.
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